Heart Test Laboratories (NASDAQ:HSCS) specializes in innovative cardiac health solutions, focusing primarily on developing and marketing advanced electrocardiogram (ECG) technologies. Their flagship project, the MyoVista wavECG Technology, aims to significantly improve the detection of heart disease by incorporating cutting-edge machine learning algorithms with traditional ECG techniques. The objective of Heart Test Laboratories is to enhance early diagnosis and monitoring of heart disease, striving to make cardiac care more accessible and effective for patients worldwide. Through continuous research and development, the company is committed to pushing the boundaries of what's possible in cardiac diagnostics, ensuring better health outcomes for individuals at risk of heart disease.